Madam Chair, elsewhere on the Hill this week, Minister of Procurement Anand testified that she had asked all of the companies that are producing vaccines for the right to produce domestically, and that she had been told no.
One of the things that CETA did was to reinforce the intellectual property protections for pharmaceutical companies. The TCA does that by extension. I'm wondering if that experience with these companies—that have seen their intellectual property rights protected in many trade agreements, including in CETA and this TCA—refusing Canada the opportunity to produce domestically has caused the government, and you particularly, Mr. Forsyth, to rethink Canada's willingness to use trade agreements to reinforce the intellectual property rights of giant pharmaceutical companies, when they so clearly are not interested in assisting Canada, even in the midst of a crisis like this?